STOCK TITAN

Dow (NYSE: DOW) targets $2B EBITDA uplift with 4,500 job cuts

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Dow Inc. is launching Transform to Outperform, a company-wide restructuring and productivity program targeting at least $2 billion in near-term Operating EBITDA improvement. The plan focuses on simplifying operations, streamlining processes, resetting the cost structure and modernizing how Dow serves customers, including expanded use of AI and automation.

The Board approved a workforce reduction of about 4,500 roles globally. Severance and related benefit costs and future cash outlays tied to the program are expected to total $600–$800 million, with $70–$90 million to implement the workforce reduction. Overall one-time costs for Transform to Outperform are projected at $1.1–$1.5 billion, and Dow targets Op. EBITDA uplift of $500 in 2026, $1,200 incremental in 2027 and $300 incremental in 2028, with cash outlays primarily over the next two years.

Positive

  • Large targeted EBITDA uplift: Transform to Outperform targets at least $2 billion in near-term Operating EBITDA improvement, with planned Op. EBITDA gains of $500 in 2026, $1,200 incremental in 2027 and $300 incremental in 2028.
  • Structured, multi-year transformation plan: Dow presents a detailed three-year roadmap with quantified benefits and estimated cash costs, emphasizing productivity gains, growth initiatives and modernization using AI and automation.

Negative

  • Significant restructuring and cash costs: One-time costs are estimated at $1.1–$1.5 billion, including $600–$800 million in severance and additional implementation expenses, with most cash outlays concentrated over the next two years.
  • Workforce reduction of about 4,500 roles: The program includes a substantial global headcount reduction, which may create execution risk and potential disruption as the company simplifies and reorganizes its operations.

Insights

Dow outlines a large restructuring targeting $2 billion EBITDA uplift with sizable near-term cash costs and job cuts.

Dow is initiating its Transform to Outperform program, aiming for at least $2 billion in near-term Operating EBITDA improvement. Management expects roughly two thirds of the uplift from productivity and one third from growth, supported by AI, automation and a simplified operating model.

The company projects total one-time costs of $1.1–$1.5 billion, including $600–$800 million in severance linked to about 4,500 role reductions and $500–$700 million of other costs. A table shows targeted Op. EBITDA uplift of $500 in-year in 2026, $1,200 incremental in 2027 and $300 incremental in 2028.

Estimated cash costs to achieve are $800–$1,000 in 2026 and $300–$500 in 2027, with none listed for 2028. Cash outlays are expected to occur primarily over the next two years, indicating a period of higher restructuring spend before the full EBITDA benefits are realized.

0001751788FALSE0000029915FALSE0001751788dow:TheDowChemicalCompanyMember2026-01-262026-01-2600017517882026-01-262026-01-260001751788dow:A0500NotesDueMarch152027Memberdow:TheDowChemicalCompanyMember2026-01-262026-01-260001751788dow:A1125NotesDueMarch152032Memberdow:TheDowChemicalCompanyMember2026-01-262026-01-260001751788dow:A1875NotesDueMarch152040Memberdow:TheDowChemicalCompanyMember2026-01-262026-01-260001751788dow:A4625NotesDueOctober12044Memberdow:TheDowChemicalCompanyMember2026-01-262026-01-26

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
January 29, 2026 (January 26, 2026)

dowdiamondredrgb819a01.jpg

Commission
File Number
Exact Name of Registrant as Specified in its Charter,
Principal Office Address and Telephone Number
State of Incorporation or
Organization
I.R.S. Employer
Identification No.
001-38646Dow Inc.Delaware30-1128146
2211 H.H. Dow Way, Midland, MI 48674
(989) 636-1000
001-03433The Dow Chemical CompanyDelaware38-1285128
2211 H.H. Dow Way, Midland, MI 48674
(989) 636-1000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
RegistrantTitle of each classTrading Symbol(s)Name of each exchange on which registered
Dow Inc.Common Stock, par value $0.01 per shareDOWNew York Stock Exchange
The Dow Chemical Company0.500% Notes due March 15, 2027DOW/27New York Stock Exchange
The Dow Chemical Company1.125% Notes due March 15, 2032DOW/32New York Stock Exchange
The Dow Chemical Company1.875% Notes due March 15, 2040DOW/40New York Stock Exchange
The Dow Chemical Company4.625% Notes due October 1, 2044DOW/44New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Dow Inc.Emerging Growth Company
The Dow Chemical CompanyEmerging Growth Company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Dow Inc.The Dow Chemical Company



Section 2 - Financial Information

Item 2.05 Costs Associated with Exit or Disposal Activities.

On January 29, 2026, Dow Inc. ("Dow" or the "Company") announced Transform to Outperform, a comprehensive set of actions designed to improve near-term Operating EBITDA by simplifying the Company’s operating model, reducing its cost structure and delivering faster growth. On January 26, 2026, the Company’s Board of Directors approved certain severance and related benefit costs for a workforce reduction of approximately 4,500 roles globally related to Transform to Outperform.

The Company will record charges in 2026 and 2027 for costs associated with Transform to Outperform. In total, severance and related benefit costs and future cash outlays are expected to be in the range of $600 million to $800 million. Costs and future cash outlays to implement the workforce reduction are expected to be in the range of $70 million to $90 million. Cash outlays will occur primarily over the next two years.

The Company will involve local stakeholders as defined in each country and in compliance with relevant information and consultation processes.

As permitted by Item 2.05 of Form 8-K, the Company will file an amendment to this report if charges and future cash payments differ materially from current estimates.


Section 8 - Other Events

Item 8.01 Other Events.

The Company issued a press release on January 29, 2026, announcing Transform to Outperform. The press release is included below in its entirety.
Cropped Screenshot 2026-01-28 174527.jpg

Dow launches Transform to Outperform to raise the competitive industry benchmark for productivity and growth to enable improved returns

Targeting at least $2 billion near-term Op. EBITDA improvement
Actions aim to radically simplify the Company’s operating model, streamline its processes, reset its cost structure and modernize how it serves customers
Benefits will be accretive to 2025 earnings levels and Dow’s previously announced $1 billion cost savings program


MIDLAND, Mich. – January 29, 2026 – Dow (NYSE: DOW) today announced a comprehensive plan to simplify how it operates and streamline its end-to-end processes. The Company will also reset its cost structure and modernize how it serves customers. Transform to Outperform targets the addition of at least $2 billion in near-term Op. EBITDA, in part by utilizing AI and automation to deliver step change in growth and productivity and improve shareholder returns.



®TM Trademark of The Dow Chemical Company (“Dow”) or an affiliated company of Dow



A simpler, more efficient Dow
“The goal of Transform to Outperform is to achieve significant growth and productivity gains that elevate Dow’s competitive position,” said Karen S. Carter, Dow’s chief operating officer. “We are building on the momentum of our current self-help measures – transforming Dow into a company that is more resilient, consistently delivers growth, enables customer success, and delivers greater shareholder value across the cycle.”

Key transformation goals & benefits
This work represents an ongoing intensive, company-wide analysis and Dow has established a dedicated internal team to guide the transformation. The Company expects to provide at least $2 billion in near-term Op. EBITDA uplift. Dow’s current projections are that approximately two thirds of the benefits will be from productivity improvements and one third from growth.

The Company anticipates ~$1.1-1.5 billion in one-time costs associated with Transform to Outperform, including ~$600-800 million in severance for ~4,500 Dow roles and ~$500-700 million in other one-time costs.

YearTarget Op. EBITDA ($MM)Est. Cash Cost to Achieve ($MM)
2026$500 in-year$800-1,000 in year
2027$1,200 incremental$300-500 in-year
2028$300 incremental$0

A commitment to long-term strength and competitiveness
"Transform to Outperform will drive significant simplification in how work gets done, aimed at ensuring Dow’s continued global leadership,” said Jim Fitterling, Dow chair and CEO. “By leveraging best-in-class, cross-industry processes and leading-edge technologies, this work will further accelerate measures we have already taken to address the prolonged trough and structural industry challenges. Our efforts will build on Dow’s strong focus on safe and reliable operations while driving increased accountability and continuous improvement. This work aims to deliver improved growth, productivity and shareholder returns.”

As Dow implements the actions announced today, the Company will engage local stakeholders in each region and in compliance with local regulations and consultation processes.

About Dow
Dow (NYSE: DOW) is one of the world’s leading materials science companies, serving customers in high-growth markets such as packaging, infrastructure, mobility and consumer applications. Our global breadth, asset integration and scale, customer-focused innovation and leading business positions enable us to achieve profitable growth and help deliver a sustainable future. We operate manufacturing sites in 29 countries and employ approximately 34,600 people. Dow delivered sales of approximately $40 billion in 2025. References to Dow or the Company mean Dow Inc. and its subsidiaries. Learn more about us at www.dow.com.

###

For further information, please contact:

INVESTORS:MEDIA:
Andrew RikerSarah Young
ajriker@dow.comsyoung3@dow.com



Cautionary Statement about Forward-Looking Statements

Certain statements in this press release are “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements often address expected future business and financial performance, financial condition, and other matters, and often contain words or phrases such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “opportunity,” “outlook,” “plan,” “project,” “seek,” “should,” “strategy,” “target,” “will,” “will be,” “will continue,” “will likely result,” “would” and similar expressions, and variations or negatives of these words or phrases.

Forward-looking statements are based on current assumptions and expectations of future events that are subject to risks, uncertainties and other factors that are beyond Dow’s control, which may cause actual results to differ materially from those projected, anticipated or implied in the forward-looking statements and speak only as of the date the statements were made. These factors include, but are not limited to: sales of Dow’s products; Dow’s expenses, future revenues and profitability; any sanctions, export restrictions, supply chain disruptions or increased economic uncertainty related to the ongoing conflicts between Russia and Ukraine and in the Middle East; capital requirements and need for and availability of financing; unexpected barriers in the development of technology, including with respect to Dow's contemplated capital and operating projects; Dow's ability to realize its commitment to carbon neutrality on the contemplated timeframe, including the completion and success of its integrated ethylene cracker and derivatives facility in Alberta, Canada; size of the markets for Dow’s products and services and ability to compete in such markets; Dow’s ability to develop and market new products and optimally manage product life cycles; the rate and degree of market acceptance of Dow’s products; significant litigation and environmental matters and related contingencies and unexpected expenses; the success of competing technologies that are or may become available; the ability to protect Dow’s intellectual property in the United States and abroad; developments related to contemplated restructuring activities and proposed divestitures or acquisitions such as workforce reduction, manufacturing facility and/or asset closure and related exit and disposal activities, and the benefits and costs associated with each of the foregoing; fluctuations in energy and raw material prices; management of process safety and product stewardship; changes in relationships with Dow’s significant customers and suppliers; changes in public sentiment and political leadership; increased concerns about plastics in the environment and lack of a circular economy for plastics at scale; changes in consumer preferences and demand; changes in laws and regulations, political conditions, tariffs and trade policies, or industry development; global economic and capital markets conditions, such as inflation, market uncertainty, interest and currency exchange rates, and equity and commodity prices; business, logistics, and supply disruptions; security threats, such as acts of sabotage, terrorism or war, including the ongoing conflicts between Russia and Ukraine and in the Middle East; weather events and natural disasters; disruptions in Dow’s information technology networks and systems, including the impact of cyberattacks; risks related to Dow’s separation from DowDuPont Inc. such as Dow’s obligation to indemnify DuPont de Nemours, Inc. and/or Corteva, Inc. for certain liabilities; and any global and regional economic impacts of a pandemic or other public health-related risks and events on Dow’s business.

Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. A detailed discussion of principal risks and uncertainties which may cause actual results and events to differ materially from such forward-looking statements is included in the section titled “Risk Factors” contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, and the Company's subsequent reports filed with the U.S. Securities and Exchange Commission. These are not the only risks and uncertainties that Dow faces. There may be other risks and uncertainties that Dow is unable to identify at this time or that Dow does not currently expect to have a material impact on its business. If any of those risks or uncertainties develops into an actual event, it could have a material adverse effect on Dow’s business. Dow Inc. and The Dow Chemical Company and its consolidated subsidiaries assume no obligation to update or revise publicly any forward-looking statements whether because of new information, future events, or otherwise, except as required by securities and other applicable laws.

®TM Trademark of The Dow Chemical Company or an affiliated company of Dow



Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

DOW INC.
THE DOW CHEMICAL COMPANY
Date: January 29, 2026


/s/ ANDREA L. DOMINOWSKI
Andrea L. Dominowski
Controller and Vice President
of Controllers





FAQ

What is Dow (DOW) announcing in its Transform to Outperform plan?

Dow is launching Transform to Outperform, a company-wide program targeting at least $2 billion in near-term Operating EBITDA improvement. The plan focuses on simplifying operations, streamlining processes, resetting the cost structure and modernizing customer service, including using AI and automation to enhance growth and productivity.

How many jobs will Dow (DOW) cut under Transform to Outperform?

Dow’s Board approved a workforce reduction of approximately 4,500 roles globally as part of Transform to Outperform. These reductions are tied to severance and related benefit costs estimated at $600–$800 million, with additional implementation costs and cash outlays primarily over the next two years.

What financial benefits does Dow (DOW) expect from Transform to Outperform?

Dow targets at least $2 billion in near-term Operating EBITDA uplift from Transform to Outperform. Current projections show about two thirds of benefits from productivity improvements and one third from growth, with Op. EBITDA gains of $500 in 2026, $1,200 incremental in 2027 and $300 incremental in 2028.

What one-time costs will Dow (DOW) incur for Transform to Outperform?

Dow anticipates $1.1–$1.5 billion in one-time costs for Transform to Outperform. This includes $600–$800 million in severance for about 4,500 roles and $500–$700 million in other costs, with cash spending largely occurring during 2026 and 2027 according to the company’s estimates.

How will Transform to Outperform affect Dow’s (DOW) cash outlays over time?

Dow expects most cash outlays for Transform to Outperform over the next two years. Estimated cash costs total $800–$1,000 in 2026 and $300–$500 in 2027, with no additional cash costs listed for 2028, while targeted Operating EBITDA benefits phase in across those same years.

What are Dow’s (DOW) yearly Operating EBITDA targets under Transform to Outperform?

Dow’s table shows a target of $500 in-year Operating EBITDA uplift in 2026, $1,200 incremental uplift in 2027, and $300 incremental uplift in 2028. These figures are part of the broader goal to add at least $2 billion in near-term Operating EBITDA through productivity and growth initiatives.
Dow Inc

NYSE:DOW

DOW Rankings

DOW Latest News

DOW Latest SEC Filings

DOW Stock Data

19.48B
709.42M
0.18%
69.17%
3.54%
Chemicals
Plastic Materials, Synth Resins & Nonvulcan Elastomers
Link
United States
MIDLAND